Brief: Qiagen & Incyte Announce Precision Medicine Collaboration To Develop Companion Diagnostics For Patients With Mutant Calr-Expressing Myeloproliferative Neoplasms
15/06/2025 09:07
June 15 (Reuters) - Incyte Corp INCY.O: QIAGEN AND INCYTE ANNOUNCE PRECISION MEDICINE COLLABORATION TO DEVELOP COMPANION DIAGNOSTICS FOR PATIENTS WITH MUTANT CALR-EXPRESSING MYELOPROLIFERATIVE NEOPLASMS (MPNS) INCYTE CORP - QIAGEN TO CREATE MULTIMODAL PANEL USING NGS TECHNOLOGY INCYTE CORP - DIAGNOSTIC TO IDENTIFY KEY MUTATIONS IN MPN PATIENTS INCYTE CORP - QIAGEN TO DEVELOP MULTIMODAL PANEL UNDER AGREEMENT WITH INCYTE INCYTE CORP - QIAGEN TO SUPPORT REGULATORY SUBMISSIONS IN US, EU, ASIA-PACIFIC Source text: ID:nBw9t9jlVa Further company coverage: INCY.O ((Reuters.Briefs@thomsonreuters.com;))